Cargando…

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer

OBJECTIVE: All patients with stage IB1 cervical cancer do not need to undergo parametrectomy. Some low-risk criteria for parametrial involvement (PI) have been proposed based on pathological findings. The aim of this study was to determine pretreatment risk factors for PI in stage IB1 cervical cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Hiroyuki, Todo, Yukiharu, Okamoto, Kazuhira, Yamashiro, Katsushige, Kato, Hidenori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620361/ https://www.ncbi.nlm.nih.gov/pubmed/26197769 http://dx.doi.org/10.3802/jgo.2015.26.4.255

Ejemplares similares

A prediction model of survival for patients with bone metastasis from uterine cervical cancer
por: Matsumiya, Hiroko, et al.
Publicado: (2016)

Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma
por: Yamazaki, Hiroyuki, et al.
Publicado: (2018)

Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in cervical cancer
por: Takeshita, Sho, et al.
Publicado: (2016)

Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer
por: Todo, Yukiharu, et al.
Publicado: (2016)

Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis
por: Todo, Yukiharu, et al.
Publicado: (2017)

Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer
por: Chang, Hong, et al.
Publicado: (2023)

Long-term survival of patients with recurrent endometrial stromal sarcoma: a multicenter, observational study
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort
por: Endo, Daisuke, et al.
Publicado: (2015)

The Relationship Between Parametrial Involvement and Parametrial Tissue Removed in Radical Surgery in Early-Stage Cervical Cancer
por: Birge, Ozer, et al.
Publicado: (2022)

Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery?
por: Lee, Seung-Ho, et al.
Publicado: (2018)

Identifying selection criteria for non‐radical hysterectomy in FIGO stage IB cervical cancer
por: Kasamatsu, Takahiro, et al.
Publicado: (2019)

Narrowing Resection of Parametrial Tissues Is Feasible in Low-Risk Cases of Stage IA2-IB1 Cervical Cancer
por: Li, Xue-Lian, et al.
Publicado: (2016)

Risk Factor Assessment of Lymph Node Metastasis in Patients With FIGO Stage IB1 Cervical Cancer
por: Xu, Mu, et al.
Publicado: (2022)

Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2019)

Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer
por: Jiang, Yinan, et al.
Publicado: (2021)

Nomogram Predicting Parametrial Involvement Based on the Radical Hysterectomy Specimens in the Early-Stage Cervical Cancer
por: Li, Chunbo, et al.
Publicado: (2021)

Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterion
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy
por: Kong, Tae-Wook, et al.
Publicado: (2014)

Factors predicting parametrial invasion in patients with early-stage cervical carcinomas
por: Hsu, Heng-Cheng, et al.
Publicado: (2018)

The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas
por: Brambs, Christine E., et al.
Publicado: (2019)

Nomogram Predicting the Likelihood of Parametrial Involvement in Early-Stage Cervical Cancer: Avoiding Unjustified Radical Hysterectomies
por: Benoit, Louise, et al.
Publicado: (2020)

Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage
por: Balaya, Vincent, et al.
Publicado: (2020)

Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Laparoscopic Transperitoneal Infrarenal Para-Aortic Lymphadenectomy in Patients with FIGO Stage IB1-II B Cervical Carcinoma
por: Hong, Dae G., et al.
Publicado: (2012)

Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer
por: Ding, Yan, et al.
Publicado: (2022)

Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer
por: Dabi, Yohann, et al.
Publicado: (2018)

Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
por: Chen, Xiaolin, et al.
Publicado: (2022)

Prognostic Significance of DNA Cytometry in Carcinoma of the Uterine Cervix FIGO Stage IB and II
por: Grote, Hans Jürgen, et al.
Publicado: (2001)

Reviewing FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2023)

The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2020)

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery
por: Zhang, Xiaojing, et al.
Publicado: (2020)

Association between Three Therapeutic Strategies and Clinical Outcomes of 2009 FIGO Stage IB2/IIA2 Cervical Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors
por: Fujiwara, Masateru, et al.
Publicado: (2015)

Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis
por: Cheng, Jing, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy Prior Fertility-Sparing Surgery in Women with FIGO 2018 Stage IB2 Cervical Cancer: A Systematic Review
por: Buda, Alessandro, et al.
Publicado: (2022)

Implications of the revised cervical cancer FIGO staging system
por: Bhatla, Neerja, et al.
Publicado: (2021)

Critical analysis of the FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2022)

iPMI: Machine Learning-Aided Identification of Parametrial Invasion in Women with Early-Stage Cervical Cancer
por: Charoenkwan, Phasit, et al.
Publicado: (2021)

What are the determinants of parametrial invasion in patients with early stage cervical cancer: A cross sectional study
por: Hoorshad, Niloufar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nienmncf5g262pmpjch0slesl2